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Abstract
Background: Both androgens and estrogens are necessary to ensure proper testis development and function. Studies
on endocrine disruptors have highlighted the importance of maintaining the balance between androgens and
estrogens during fetal development, when testis is highly sensitive to environmental disturbances. This balance is
regulated mainly through an enzymatic cascade that converts irreversibly androgens into estrogens. The most
important and regulated component of this cascade is its terminal enzyme: the cytochrome p450 19A1 (aromatase
hereafter). This study was conducted to improve our knowledge about its expression during mouse testis development.
Findings: By RT-PCR and western blotting, we show that full-length aromatase is expressed as early as 12.5 day
post-coitum (dpc) with maximal expression at 17.5 dpc. Two additional truncated transcripts were also detected by
RT-PCR. Immunostaining of fetal testis sections and of gonocyte-enriched cell cultures revealed that aromatase is
strongly expressed in fetal Leydig cells and at variable levels in gonocytes. Conversely, it was not detected in Sertoli cells.
Conclusions: This study shows for the first time that i) aromatase is expressed from the early stages of fetal testis
development, ii) it is expressed in mouse gonocytes suggesting that fetal germ cells exert an endocrine function in this
species and that the ratio between estrogens and androgens may be higher inside gonocytes than in the interstitial
fluid. Furthermore, we emphasized a species-specific cell localization. Indeed, previous works found that in the rat
aromatase is expressed both in Sertoli and Leydig cells. We propose to take into account this species difference as a
new concept to better understand the changes in susceptibility to Endocrine Disruptors from one species to another.
Keywords: Cyp19a1, Aromatase, Testis, Fetus, Mouse, Gonocytes, Development, Endocrine disruptors, Leydig cells,
Souris, Développement, Perturbateurs endocriniens, Cellules de Leydig
Résumé
Les androgènes et les oestrogènes sont indispensables au développement et aux fonctions du testicule. Le testicule
est particulièrement sensible aux perturbateurs endocriniens pendant le développement fœtal et beaucoup de
perturbateurs endocriniens agissent en modifiant la balance oestrogènes/androgènes. Physiologiquement, cette
balance est régulée par une cascade enzymatique qui convertit irréversiblement les androgènes en oestrogènes. Le
composant principal de cette cascade est le cytochrome p450 19A1 (appelé couramment aromatase). Le but de ce
travail a été détudier lexpression de laromatase testiculaire au cours du développement fœtal chez la souris.
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En utilisant une approche par RT-PCR et par western blot, nous avons montré que laromatase est exprimée dès
12,5 jours post-conception (jpc) et que lexpression est maximum à 17,5 jpc. Deux transcripts tronqués ont
également été détectés par RT-PCR. La localisation cellulaire de laromatase a été étudiée par immunohistologie et
par immunomarquage après séparation des cellules testiculaires. Cette enzyme est très fortement exprimée dans les
cellules de Leydig fœtales. Elle est également exprimée dans les gonocytes mais plus faiblement et à un niveau
variable selon les cellules. En revanche, elle est indétectable dans les cellules de Sertoli.
En conclusion, cette étude montre pour la première fois chez la souris que 1) laromatase est exprimée dès le début
de lontogenèse testiculaire, 2) elle est exprimée dans les gonocytes suggérant que ces cellules interviennent dans
lendocrinologie testiculaire et que le rapport oestrogènes/androgènes est plus important dans les gonocytes que
dans le liquide interstitiel. En outre, on sait que, chez le fœtus de rat laromatase est essentiellement exprimée par
les cellules de Sertoli. Nous proposons de prendre en compte cette différence inter-espèces comme un nouveau
concept pour comprendre les différences de sensibilité aux perturbateurs endocriniens dune espèce à lautre.
Mots-clés: Cyp19a1, Aromatase, Testis, Foetus, Souris, Gonocytes, Développement, Perturbateurs endocriniens,
Cellules de Leydig
Findings
Ontogenesis of cytochrome P450 aromatase expression in
the mouse testis during fetal development
C57BL/6 mice bred in our animal facility were housed
under controlled photoperiod conditions (lights from
08:00 to 20:00 h) with commercial food and tap water sup-
plied ad libitum, as previously described [1,2]. The day
after overnight mating was counted as 0.5 day post-coitum
(dpc). The animal facility is licensed by the French Minis-
try of Agriculture (agreement N°B92-032-02). All animal
experiments were supervised by Pr. René Habert (agree-
ment delivered by the French Ministry of Agriculture for
animal experimentation N°92-191) in compliance with the
NIH Guide for Care and Use of Laboratory Animals.
In this paper, we focussed on the ontogenesis of cyto-
chrome P450 aromatase (accession # NP_031836 for
protein and NM_007810.3 for mRNA), and named “aro-
matase” thereafter. To characterize aromatase expression
during mouse testis development, its mRNA level was ana-
lyzed by RT-PCR from 12.5 dpc to birth. Three transcript
variants, called T1, T2 and T3, were detected (Figure 1A-B).
T1 and T2 were observed as early as 12.5 dpc. Sequencing
confirmed that they were bona fide aromatase variants
and showed that they corresponded to full-length aroma-
tase (T1) and to the splicing variants without exon 3 (T2)
and without exons 3 and 4 (T3) (see Additional file 1).
In order to quantify these variants during embryo-
genesis, we performed quantitative real-time RT-PCR
(qRT-PCR) using the TaqMan method which allows the
detection of each isoform using three different internal
probes each one specific for one isoform (Figure 1A and
Table 1 for sequences and conditions). We showed that
T1 and T2 expression in the testis increased by around
20-fold between 13.5 and 17.5 dpc and thereafter started
to progressively decrease (Figure 1C).
To determine if aromatase is translated in mouse testis,
western blot analysis was performed using a specific
anti-aromatase antibody (MCA2077T, Serotec, France)
(Figure 1D). Two proteins around 54 kDa and one around
27 kDa were detected. The protein of 54 kDa was also
present in the ovary extract and it approximately corre-
sponds to the aromatase expected size. We thus suppose
that the two heaviest proteins derived from the full-length
form of aromatase (T1) with the highest form correspond-
ing to a testis-specific post-translational modification that
remains to be identified. In order to understand the origin
of the 27 kDa protein, we analysed sequences of the T2
and T3 variants. It revealed that the splicing of exon 3 in
T2 would change the ORF and create a precocious codon
stop leading to a probably not detected protein of 6 kDa.
Splicing of exons 3 and 4 in T3 would not change the ORF
allowing in theory the synthesis of a truncated protein of
46 kDa. No protein at this expected size was detected in
the western blot (Figure 1D). However, the use of an alter-
native start codon located later in T2 and T3 sequences
may lead to a protein of 27 kDa containing the C-terminal
part of aromatase.
These findings are different from those of the only
previously published paper on this topic showing that, in
the mouse, aromatase expression starts at 17.5 dpc and
reaches the highest level at day 1 post-partum [3]. In our
study, we detected aromatase expression as early as 12.5
dpc. This discrepancy probably results from the im-
provement of the methods of detection made since
1994. This is an important point because it shows that
estrogens can be produced by mouse fetal testes very
early and throughout development.
Our findings indicate that different aromatase transcripts
are generated in fetal mouse testes. Previous studies in dif-
ferent mammalian species (including the mouse) reported
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that tissue-specific aromatase expression is driven by spe-
cific promoters [4-6]. Each tissue-specific promoter is asso-
ciated with a specific untranslated first exon. In mice testis
Golovine et al. have shown that aromatase transcripts may
emerge from a specific promoter called Ptes [4]. Our study
showed that aromatase expression is also regulated at a
second transcriptional level generating two additional
truncated variants T2 and T3 by mRNA splicing. Our re-
sults suggest that there are several forms of aromatase pro-
tein however the nature and the physiological function of
these isoforms remain to be investigated.
Aromatase cell localization in mouse fetal testes
Immunohistochemical analysis of aromatase localization
in 17.5 dpc mouse testes using a specific anti-aromatase
antibody (MCA2077T, Serotec, France) showed a strong
staining in Leydig cells. Importantly, there was no detect-
able staining in Sertoli cells (Figure 2A). Conversely, previ-
ous studies in fetal and neonatal testes showed that
aromatase was expressed in both Leydig cells and Sertoli
cells in the rat [7,8]. This and other previous reports
indicate that aromatase cell localization in fetal testis is
quite variable in mammalian species. Indeed, aromatase is
Table 1 Sequences of aromatase primers used in RT-PCR
and qRT-PCR
Sequence 5-3 Tm
RT-PCR all
transcripts
forward AACCCCATGCAGTATAATGTC 55°C
reverse CATTCTTCTCAAAGTTTTCA
T1 qRT-PCR forward GCCTCCTTCTCCTGATTTGGA 60°C
reverse CTGCCATGGGAAATGAGGG
internal probe TACCAGGTCCTGGCTACT
T2 qRT-PCR forward GCCTCCTTCTCCTGAATTTGGA 60°C
reverse CCGAATCGGGAGATGTAGTGA
internal probe TCAATACCAGGTCCTCAAGC
T3 qRT-PCR forward CCATGCCACTCCTGCTGAT 60°C
reverse CCACCATTCGAACAAGACCAG
internal probe TCTTCAATACCAGCTCTGACGGGCC
Figure 1 Aromatase expression in mouse fetal testis. A. Scheme showing the different testis aromatase variants (T1, T2 and T3). Aromatase
exons from exon 2 to exon 10 are represented (gray boxes) for each transcript variant T1, T2 and T3. For each variant the relative position of the
RT-PCR primers (red arrows), quantitative qRT-PCR (black arrows) and internal probes (blacks lines) used are represented. B. Expression of different
aromatase transcript variants (T1, T2 and T3) during mouse testis development. Products were generated by RT-PCR with the primer
combinations E2-E9/10 (see Table 1) and visualized on 2% agarose gel. NC: 3 negative control (PCR master mix without template). M: DNA ladder;
dpc: days post-coitum; dpp: days post-partum. C. Absolute quantitative expression of aromatase transcripts during mouse testis development.
Total mRNA was isolated from fetal testes at the indicated stages of development, reverse transcribed and aromatase expression was quantified
by real-time PCR using the TaqMan method. This method allows the identification of each isoform by using a specific internal probe
(see Figure 1A for position and Table 1 for sequences). In order to calculate precisely the copy number of each transcript, each transcript was
isolated on gel, re-amplified and quantified. For each experiment a standard curve was constructed using the isolated transcript as template with
their corresponding qRT-PCR primers. Data shown are the mean ± SEM (n = 4-6). *P < 0.05 (Students t-test; compared to the mRNA copy number
at 13.5 dpc). D. Aromatase protein expression during mouse testis development. On western blots, three protein isoforms were recognized by
the anti-aromatase antibody (MCA2077T, Serotec, France). Lane A, ovary from a pregnant mouse: only one band that corresponds to the
aromatase full-length protein. Lane B, 2 dpp mouse testis; lane C and D, extracts from 15.5 and 13.5 dpc mouse testes, respectively.
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expressed in Leydig cells and not in Sertoli cells in the
fetal testis of the Plains Vizcacha rodent [9], is totally ab-
sent in the deer [10], and is detected in both Sertoli cells
and Leydig cells in fetal baboon and human testes [11,12].
In addition, our immunohistochemical analysis showed
that aromatase was also expressed in gonocytes, but the
intensity of the signal was not uniform: in some cells the
signal was very strong, whereas in others it was faint or
undetectable (Figure 2A, arrowheads). Similar results
were previously described for Retinoic Acid Receptor
alpha [14]. As aromatase localization in germ cells was
quite unexpected, aromatase immunostaining was also
performed in enriched gonocyte cultures that were pre-
pared from 17.5 dpc mouse testes as previously described
[15]. Similarly, aromatase was detected in some germ cell
VASA-positive cells, a germ cell-specific marker (Figure 2B).
This result identifies a sub-population of gonocytes with
endocrine function. Aromatase expression was previously
reported in adult rat and human germ cells [16,17] and
in pig gonocytes during development [18]. Aromatase ex-
pression was also detected in gonocytes of human fetal tes-
tes [12].
In conclusion, aromatase cell localization in fetal testis
appears to differ from one species to another and as
<
A
Aromatase3 -HSD Merge
AromataseVASA Merge
B
a b
*
*
*
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Figure 2 Aromatase cell localization in mouse fetal testis. A. Aromatase immunodetection in 17.5 dpc testes. Immunostaining was
performed using an anti-aromatase antibody (MCA2077T, Serotec, France), followed by a biotin-conjugated secondary antibody and streptavidin-
peroxidase visualization with DAB (Vector Laboratories). (a) A strong specific immunoreactivity was observed in Leydig cells within the interstitial
tissue (arrows) and to a lesser extent in gonocytes (arrowheads). Inset is a higher magnification to show that aromatase is localized only in the
cytoplasm of Leydig cells (arrows) and gonocytes (arrowheads) and is absent or not detectable in the Sertoli cells (asterisks). (b) Control section
(ovary from adult pregnant rat): positive staining is observed in the corpora lutea (CL) but not in the pre-antral follicle (F), as previously described
[13]. Scale bars = 5 μm. B. Double immunofluorescence staining for aromatase, 3βHSD (Leydig cell marker) and VASA (germ cell marker) in
enriched gonocyte cultures. Immunostaining was performed using anti-aromatase (MCA2077T, Serotec, France) (green), anti-3βHSD (generous gift
by J.I Mason) (red) and anti-VASA antibodies (ab13840, Abcam, France) (red). Aromatase expression was detected both in 3βHSD-positive cells
and in VASA-positive cells. Nuclei were visualized with 4-6 diaminido-2-phenylindole (DAPI) (blue). Scale bars = 10 μm.
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consequence also the intracellular estrogen concentra-
tion. These differences should be taken into account to
explain the variations in the susceptibility of fetal testis
to estrogenic and anti-androgenic endocrine disruptors
in different mammalian species that has been recently
lightened [2].
Additional file
Additional file 1: Sequencing results of T1, T2 and T3. The three
different transcripts were isolated on gel and sequenced with the
following primers: forward 5-AACCCCATGCAGTATAATGTC-3 (located in
exon II); reverse 5-CACAATAGCACTTTCGTCCA-3 (located in exon V). Each
different exon is highlighted in a different color (red exon II, black exon
III, and blue exon IV and green exon V. In addition, sequencing from
exons VI to X were performed using other primers and showed no
difference in T1, T2 and T3 (data not shown).
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